Shareholders of Biohaven Ltd. Should Contact The Gross Law Firm Before September 12, 2025 to Discuss Your Rights – BHVN

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Biohaven Ltd. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's product candidates [1][3]. Group 1: Class Action Details - The class period for the lawsuit is from March 24, 2023, to May 14, 2025 [3]. - Allegations include that Biohaven overstated the regulatory prospects of its product candidate, troriluzole, and the efficacy of BHV-7000 for bipolar disorder [3]. - The lawsuit claims that the misleading statements are likely to have a significant negative impact on Biohaven's business and financial condition [3]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of September 12, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].